SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-075355
Filing Date
2012-11-07
Accepted
2012-11-07 16:14:40
Documents
2
Period of Report
2012-11-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-26326_18k.htm 8-K 23555
2 EX-99.1 a12-26326_1ex99d1.htm EX-99.1 236305
  Complete submission text file 0001104659-12-075355.txt   261074
Mailing Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302 (201) 333-8819
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 121186930
SIC: 2834 Pharmaceutical Preparations